About clinical trials
Australia is a global leader in clinical trials, offering a top-tier environment for research and ensuring patients receive the best treatments.
Australia: A global hub for clinical trials
Clinical trials are essential in the research and development pipeline for new treatments, as well as for refining and repurposing existing therapies. They are crucial in ensuring that Australian patients receive the best, safest, and most effective treatments.
Australia provides a comprehensive, seamless solution for cutting-edge clinical trials. It is internationally recognised for its highly trained workforce and high-quality research.
National clinical trials impact
In 2022, 1,850 trials were started in Australia, employing approximately 7,700 Australians and involving approximately 90,000 Australians as trial participants.
This activity saw approximately $1.6 billion spent on clinical trials, up from approximately $1.4 billion in 2019.
How HTQ is supporting the clinical trials ecosystem
Through the Clinical Trials Hub, HTQ actively supports researchers and clinical trial teams throughout the clinical trials process.
The Hub provides access to top education resources and useful information from across the web in one central location, as well as targeted blogs developed in consultation with some of Queensland’s top clinical trial experts.
References
MPT Connect https://www.mtpconnect.org.au/images/MTPConnect_2024_AustraliasClinicalTrialsSectorReport.pdf page 17
